Mei Pharma Correlations

MEIP
 Stock
  

USD 0.42  0.01  2.44%   

The correlation of Mei Pharma is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mei Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mei Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Additionally, see Correlation Analysis.
  
The ability to find closely correlated positions to Mei Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mei Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mei Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mei Pharma to buy it.

Moving together with Mei Pharma

+0.71FNMFOFed Natl MtgPairCorr

Moving against Mei Pharma

-0.61SGMLSigma Lithium CorpPairCorr
-0.57IBAIndustrias BachocoPairCorr

Related Correlations

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

The Correlation Coefficient is a useful tool to identify correlated or non-correlated securities, which is essential in developing a diversified portfolio. It tells us the relationship between two positions you have in your portfolio or considering acquiring. Over a given time period, the two securities movetogether when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
AF
CRMMSFT
FUBER
MRKT
AUBER
UBERTWTR
  
High negative correlations   

Mei Pharma Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Mei Pharma Stock performing well and Mei Pharma company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Mei Pharma's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
TWTR 1.64  0.18  0.06  0.19  2.79  0.07 (1.53)  4.00 (2.55)  15.22 
MSFT 1.41 (0.02)  0.00 (0.06)  0.00 (0.0196)  0.00  2.78 (3.17)  12.18 
UBER 2.88  0.52  0.15  0.36  2.75  0.13 (3.15)  5.60 (4.70)  25.11 
F 2.19  0.23  0.06  0.08  3.07  0.06 (2.34)  5.18 (3.74)  18.47 
T 1.00 (0.33)  0.00 (0.54)  0.00 (0.21)  0.00  1.65 (2.33)  9.46 
A 1.66  0.20  0.10  0.11  1.85  0.08 (1.85)  3.43 (3.13)  11.70 
CRM 2.13 (0.09)  0.00 (0.10)  0.00 (0.0457)  0.00  3.94 (4.55)  12.87 
JPM 1.30 (0.02)  0.00 (0.07)  0.00 (0.0179)  0.00  2.61 (2.88)  8.06 
MRK 0.97 (0.02)  0.00 (0.09)  0.00  0.0044  0.00  2.10 (2.13)  6.12 
XOM 1.77  0.01  0.00 (0.04)  0.00  0.0115  0.00  3.19 (3.69)  8.84 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Mei Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Competition Analyzer Now

   

Competition Analyzer

Analyze and compare many basic indicators for a group of related or unrelated entities
All  Next Launch Module

Mei Pharma Corporate Directors

Mei Pharma corporate directors refer to members of a Mei Pharma board of directors. The board of directors generally takes responsibility for the Mei Pharma's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Mei Pharma's board members must vote for the resolution. The Mei Pharma board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Leah Cann - Independent DirectorProfile
Thomas Reynolds - Independent DirectorProfile
William Rueckert - Independent DirectorProfile
Kevan Clemens - Independent DirectorProfile

Invested in Mei Pharma?

The danger of trading Mei Pharma is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Mei Pharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Mei Pharma. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Mei Pharma is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additionally, see Correlation Analysis. You can also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for analysis

When running Mei Pharma price analysis, check to measure Mei Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mei Pharma is operating at the current time. Most of Mei Pharma's value examination focuses on studying past and present price action to predict the probability of Mei Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Mei Pharma's price. Additionally, you may evaluate how the addition of Mei Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Is Mei Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mei Pharma. If investors know Mei Pharma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mei Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Mei Pharma is measured differently than its book value, which is the value of Mei Pharma that is recorded on the company's balance sheet. Investors also form their own opinion of Mei Pharma's value that differs from its market value or its book value, called intrinsic value, which is Mei Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mei Pharma's market value can be influenced by many factors that don't directly affect Mei Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mei Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Mei Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mei Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.